Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: Potential role in idiopathic pulmonary fibrosis

American Journal of Pathology

Volumn 166, Issue 5, 2005, Pages 1321-1332

  Willis, Brigham C ^a,b,c   Liebler, Janice M ^b   Luby Phelps, Katherine ^c   Nicholson, Andrew G ^d   Crandall, Edward D ^b   Du Bois, Roland M ^d   Borok, Zea ^b,e  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AQUAPORIN 5; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; CYTOKERATIN; DESMIN; PROTEIN ZO1; SURFACTANT PROTEIN B; THYROID TRANSCRIPTION FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RAT; SAMPLING;

EID: 17844384822     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62351-6     Document Type: Article

References (61)

1. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE Jr, Leinwand LA, Liotta L, Martin GR, Schwartz DM, Schultz GS, Wagner CR, Musson RA: Future research directions in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2002, 166:236-246
2. Travis WD, King TE Jr, Bateman ED, Lynch DA: American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Resp Crit Care Med 2002, 265:277-304
3. Selman M, Pardo A: The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S93-S96
4. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G, Doglioni C: Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003, 162:1495-1502
5. Pittet JF, Griffiths MJD, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LAS, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D: TGF-β is a critical mediator of acute lung injury. J Clin Invest 2001, 107:1537-1544
6. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J: Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis. J Immunol 2004, 173:2099-2108
7. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J: Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997, 100:768-776
8. Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, Khalil N: Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol 2003, 285:L527-L539
9. Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, Hance A, Tazi A: Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. Eur Respir J 2003, 22:69-76
10. Dhainaut J-F, Charpentier J, Chiche J-D: Transforming growth factor-β: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 2003, 31:3258-3264
11. Boyer B, Valles AM, Edme N: Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000, 60:1091-1099
12. Serini G, Gabbiani G: Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999, 250:273-283
13. Schurch W, Seemayer TA, Gabbiani G: The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 1998, 22:141-147
14. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004, 113:243-252
15. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, Gauldie J: Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol 1998, 153:825-832
16. Zhang K, Phan S: Cytokines and pulmonary fibrosis. Biol Signals 1996, 5:232-239
17. Borok Z, Danto S, Zabski S, Crandall ED: Defined medium for primary culture de novo of rat alveolar epithelial cells. In Vitro Cell Dev Biol Anim 1994, 30A:99-104
18. Kao WW-Y, Prockop DJ: Proline analogue removes fibroblasts from cultured mixed cell populations. Nature 1977, 266:63-64
19. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
20. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 1979, 76:43-50
21. Holmes TJ, O'Connor NJ: Blind deconvolution of 3D transmitted light brightfield micrographs. J Microsc 2000, 200:114-127
22. Munger JS, Huang X, Kawakatsu H, Griffiths MJD, Dalton SL, Wu J, Rittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D: The integrin αvβ6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328
23. Sime PJ, O'Reilly KMA: Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001, 99:308-319
24. Pardo A, Selman M: Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem Cell Biol 2002, 34:1534-1538
25. Jaffe HA, Gao Z, Mori Y, Li L, Varga J: Selective inhibition of collagen gene expression in fibroblasts by an interferon-gamma transgene. Exp Lung Res 1999, 25:199-215
26. Ziesche R, Hofbauer E, Wittman K, Petkov V, Block LH: A preliminary study of long-term treatment with interferon-gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999, 341:1264-1269
27. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DM, King TE Jr: A placebo-conttolied trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004, 350:125-133
28. Maniscalco WM, Campbell MH: Transforming growth factor-β induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells. Am J Physiol 1994, 266:L672-L680
29. Maniscalco WM, Sinkin RA, Watkins RH, Campbell MH: Transforming growth factor-β1 modulates type II cell fibronectin and surfactant protein C expression. Am J Physiol 1994, 267:L569-L577
30. Li C, Zhu N-LZ, Tan RC, Ballard PL, Derynck R, Minoo P: Transforming growth factor-β inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NHX2.1 and HNF-3 transcription factors. J Biol Chem 2002, 277:38399-38408
31. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004, 202:145-156
32. Kelly M, Kolb M, Bonniaud P, Gauldie J: Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 2003, 9:39-49
33. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349
34. Miyazaki M, Araki Y, Vesin C, Garcia I, Kapanci Y, Whitsett J, Piguet P, Vassalli P: Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis. J Clin Invest 1995, 96:250-259
35. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T, Gressner AM: Tumor necrosis factor alpha and transforming growth factor beta 1 stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch 1993, 63:123-130
36. Bates RC, Mercurio AM: Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 2003, 14:1790-1800
37. Iyonaga K, Miyajima M, Suga M, Saita N, Ando M: Alterations in cytokeratin expression by the alveolar lining epithelial cells in lung tissues from patients with idiopathic pulmonary fibrosis. J Pathol 1997, 182:217-224
38. Xu YD, Hua J, O'Connor R, Khalil N: Chronic release of active TGF-β1 by the alveolar epithelial cell (AEC) line, L-2 results in connective tissue (CT) synthesis and conversion of L-2 cells to a fibroblast-like phenotype. Am J Respir Crit Care Med 2003, 67:A572
39. Miettinen PJ, Ebner R, Lopez AR, Derynck R: TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994, 127:2021-2036
40. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002, 110:341-350
41. Fan J-M, Ng Y-Y, Hill PA, Nikolic-Paierson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999, 56:1455-1467
42. Fujigaki Y, Sun DF, Fujimoto T, Suzuki T, Goto T, Yonemura K. Morioka T, Yaoita E, Hishida A: Mechanisms and kinetics of Bowman's epithelial- myofibroblast transdifferentiation in the formation of glomerular crescents. Nephron 2002, 92:203-212
43. Grande M, Franzen A, Karlsson J-O, Ericson LE, Heldin N-E, Nilsson M: Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 2002, 115:4227-4236
44. Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784
45. Kim KJ, Fandy TE, Lee VH, Ann DK, Borok Z, Crandall ED: Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 2004, 287:L616-L622
46. Widera A, Kim KJ, Crandall ED, Shen WC: Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers. Pharm Res 2003, 20:1231-1238
47. Sexton DW, Blaylock MG, Walsh GM: Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin- and phosphatidylserine receptor-dependent mechanisms: a process upregulated by dexamethasone. J Allergy Clin Immunol 2001, 108:962-969
48. Hastings RH, Folkesson HG, Petersen V, Ciriales R, Matthay MA: Cellular uptake of albumin from lungs of anesthetized rabbits. Am J Physiol 1995, 269:L453-L462
49. Hastings RH, Wright JR, Albertine KH, Ciriales R, Matthay MA: Effect of endocytosis inhibitors on alveolar clearance of albumin, immunoglobulin G, and SP-A in rabbits. Am J Physiol 1994, 266:L544-L552
50. Zhao Y, Young S: Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth inhibition. J Biol Chem 1996, 271:2369-2372
51. Banner J, Badgett A, Lindroos P, Osornio-Vargas A: Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro. Am J Respir Cell Mol Biol 1995, 13:496-505
52. Fine A, Goldstein R: The effect of transforming gtowth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 1987, 262:3897-3902
53. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL: Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001, 12:27-36
54. Yu L, Hebert MC, Zhang YE: TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 2002, 21:3749-3759
55. Masszi A, Di Ciano C, Sirokmany G, Arthur WT, Rotstein OD, Wang J, McCulloch CAG, Rosivall L, Mucsi I, Kapus A: Central role for Rho in TGF-β1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol 2003, 284:F911-F924
56. Li Y, Yang J, Dai C, Wu C, Liu Y: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003, 112:503-516
57. Schramek H, Feifel E, Marschitz I, Golochichapova N, Gstraunthaler G, Montesano R: Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. Am J Physiol 2003, 285:C652-C661
58. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003, 9:964-968
59. Kim K, Lu Z, Hay ED: Direct evidence for a role of β-calenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002, 26:463-476
60. Cano A, Perez-Moreno M, Rodrigo I, Locascio A, Blanco M, del Barr M, Portillo F, Nieto M: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2:76-83
61. Kang Y, Hebron H, Ozbun L, Mariano J, Minoo P, Jakowlew SB: Nkx2.1 transcription factor in lung cells and a transforming growth factor-β1 heterozygous mouse model of lung carcinogenesis. Mol Carcinog 2004, 40:212-231